All malaria infections are harmful to both the pregnant mother and the developing fetus. One
in ten maternal deaths in malaria endemic countries are estimated to result from …

Introduction: Malaria in pregnancy and postpartum cause maternal mortality and adverse
fetal outcomes. Efficacious and safe antimalarials are needed to treat and prevent such …

Background Drug safety assessments in clinical trials present unique analytical challenges.
Some of these include adjusting for individual follow-up time, repeated measurements of …

Background There is no agreed standard method to assess the efficacy of anti-malarials for
uncomplicated falciparum in pregnancy despite an increased risk of adverse outcomes for …

Background Malaria in pregnancy, including asymptomatic infection, has a detrimental
impact on foetal development. Individual patient data (IPD) meta-analysis was conducted to …

Artemisinin combination therapy (ACT) is recommended by the World Health Organization
(WHO) as first line treatment for uncomplicated malaria both in adults and children. During …

Background Reports on the occurrence and outcome of Visceral Leishmaniasis (VL) in
pregnant women is rare in published literature. The occurrence of VL in pregnancy is not …

Introduction: le paludisme chez la femme enceinte est un problème majeur de santé
publique en Afrique. Il a des conséquences graves aussi bien sur la mère, le fœtus que le …

Résumé Introduction: le paludisme chez la femme enceinte est un problème majeur de
santé publique en Afrique. Il a des conséquences graves aussi bien sur la mère, le fœtus …

Introduction Pregnant women are more vulnerable to malaria leading to adverse impact on
both mothers and fetuses. However, knowledge on the efficacy and safety of antimalarials in …